Search

Fortrea Holdings Inc.

Cerrado

SectorSanidad

18.07 2.32

Resumen

Variación precio

24h

Actual

Mínimo

17.45

Máximo

18.31

Métricas clave

By Trading Economics

Ingresos

8.9M

-24M

Ventas

-24M

637M

BPA

0.16

Margen de beneficios

-3.708

Empleados

14,000

EBITDA

20M

26M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-11.79% downside

Dividendos

By Acuity

Próximas Ganancias

29 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

518M

1.7B

Apertura anterior

15.75

Cierre anterior

18.07

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

145 / 340 Clasificación en Healthcare

Fortrea Holdings Inc. Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 jul 2026, 19:56 UTC

Fortrea Holdings Inc shares are lower today, continuing a decline since Friday's close. No specific news has been identified to explain the movement.

Comparación entre iguales

Cambio de precio

Fortrea Holdings Inc. previsión

Precio Objetivo

By TipRanks

-11.79% descenso

Estimación a 12 Meses

Media 15.64 USD  -11.79%

Máximo 20 USD

Mínimo 9.5 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortrea Holdings Inc. Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

5

Comprar

4

Mantener

1

Vender

Sentimiento

By Acuity

145 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.